A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Non Small Cell Lung Cancer|Pancreatic Ductal Adenocarcinoma|Triple Negative Breast Cancer|Colorectal Cancer
Interventions: BIOLOGICAL: CAN04|DRUG: Cisplatin|DRUG: Gemcitabine|DRUG: Nab-paclitaxel|DRUG: Carboplatin|DRUG: Pemetrexed
Sponsor: Cantargia AB